Causes of jaundice in neonates based on day of life
neonatal jaundice causes by day of life classification
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 9341
neonatal hyperbilirubinemia etiology physiological pathological
Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation
Page 5
neonatal jaundice day 1 hemolytic disease ABO Rh incompatibility
prolonged neonatal jaundice breast milk jaundice hypothyroidism causes
| Cause | Mechanism |
|---|---|
| Rh incompatibility (Rh hemolytic disease) | Maternal anti-D IgG crosses placenta β fetal RBC destruction |
| ABO incompatibility | Maternal anti-A or anti-B IgG β hemolysis |
| Other blood group incompatibility (Kell, Duffy, Kidd) | Alloimmune hemolysis |
| Congenital infections (TORCH) | CMV, rubella, toxoplasmosis, syphilis β hemolysis + hepatitis |
| G6PD deficiency | Enzyme deficiency β oxidative hemolysis (can present day 1) |
| Cause | Type | Notes |
|---|---|---|
| Physiological jaundice | Unconjugated | Most common; due to immature UGT1A1, high RBC turnover, enterohepatic circulation. Peaks day 3β4 in term infants |
| Prematurity | Unconjugated | More profound due to greater hepatic immaturity |
| Polycythemia | Unconjugated | Increased RBC breakdown β more bilirubin load |
| Cephalohematoma / bruising | Unconjugated | Extravascular blood breakdown |
| ABO/Rh incompatibility (ongoing) | Unconjugated | If not treated from day 1 |
| G6PD deficiency | Unconjugated | Can manifest on day 2β3, especially with oxidant exposure |
| Cause | Type | Notes |
|---|---|---|
| Breast milk jaundice (early / breastfeeding jaundice) | Unconjugated | Due to inadequate intake β increased enterohepatic circulation |
| Sepsis / infection | Conjugated or unconjugated | E. coli, Staph β hemolysis or hepatic dysfunction |
| Crigler-Najjar syndrome (Type I & II) | Unconjugated | Complete or partial UGT1A1 deficiency |
| Gilbert syndrome | Unconjugated | Mild; often incidental |
| Hypothyroidism / hypopituitarism | Unconjugated | Impaired hepatic maturation |
| Pyloric stenosis | Unconjugated | Increased enterohepatic circulation |
| Hemolytic anemias (hereditary spherocytosis, elliptocytosis) | Unconjugated | RBC membrane defects |
| Cause | Notes |
|---|---|
| Breast milk jaundice (late) | Most common cause of prolonged jaundice; benign; mediated by Ξ²-glucuronidase in breast milk increasing enterohepatic circulation |
| Hypothyroidism | Screen with TSH/T4; neonatal screening programs |
| Hemolytic disease (ongoing) | G6PD, spherocytosis, etc. |
| Crigler-Najjar | Severe, persistent unconjugated hyperbilirubinemia |
| Cause | Notes |
|---|---|
| Biliary atresia | Most urgent β requires Kasai procedure before 8 weeks; hallmark is acholic stools + dark urine |
| Neonatal hepatitis (idiopathic or viral) | CMV, hepatitis B, EBV |
| Choledochal cyst | Biliary dilation |
| Alagille syndrome | Bile duct paucity + dysmorphic features |
| Total parenteral nutrition (TPN) cholestasis | Common in premature infants on prolonged TPN |
| Alpha-1 antitrypsin deficiency | Metabolic liver disease |
| Galactosemia / tyrosinemia | Metabolic disorders |
| Progressive familial intrahepatic cholestasis (PFIC) | Genetic bile transport defects |
| Sepsis-associated cholestasis | E. coli UTI particularly implicated |
| Timing | Pattern | Common Causes |
|---|---|---|
| < 24 hours | Always pathological | Rh/ABO incompatibility, TORCH, G6PD |
| Day 2β3 | Physiological peak | Physiological jaundice, prematurity, cephalohematoma |
| Day 4β7 | Mixed | Breastfeeding jaundice, sepsis, hemolytic anemias, metabolic |
| > 2 weeks (term) / > 3 weeks (preterm) | Prolonged | Breast milk jaundice (unconj.), biliary atresia (conj.) β must split bilirubin |
Reticulocyte count
reticulocyte count corrected reticulocyte index interpretation anemia
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 1764
reticulocyte production index hypoproliferative hyperproliferative anemia classification
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 1775
reticulocyte count formula correction hematocrit maturation factor calculation
reticulocyte count anemia classification algorithm

Harrison's Principles of Internal Medicine, Twenty First Edition
Page 1774
| Hematocrit | Maturation Factor |
|---|---|
| 45% | 1.0 |
| 35% | 1.5 |
| 25% | 2.0 |
| 15% | 2.5 |

| Category | Examples |
|---|---|
| Blood loss | Acute hemorrhage (GI bleed, trauma) |
| Hemolysis β immune | AIHA, transfusion reaction, drug-induced |
| Hemolysis β intrinsic RBC defect | G6PD deficiency, hereditary spherocytosis, sickle cell |
| Hemolysis β intravascular | TTP/HUS, DIC, mechanical heart valves |
| Hemolysis β hemoglobinopathy | Sickle cell crisis, thalassemia |
| Cause | Notes |
|---|---|
| Iron deficiency (early) | MCV normal early on |
| Anemia of chronic disease | Most common cause in hospitalized patients |
| Renal failure | β EPO production |
| Bone marrow aplasia | Aplastic anemia |
| Bone marrow infiltration | Leukemia, myeloma, myelofibrosis |
| Hypothyroidism / hypopituitarism | β EPO stimulus |
| Cause | Notes |
|---|---|
| Iron deficiency anemia | Most common anemia worldwide |
| Thalassemia | Ineffective erythropoiesis |
| Sideroblastic anemia | Ringed sideroblasts on marrow |
| Anemia of chronic disease | Can be microcytic |
| Cause | Notes |
|---|---|
| Vitamin B12 deficiency | Megaloblastic; hypersegmented neutrophils |
| Folate deficiency | Megaloblastic |
| Myelodysplastic syndrome | Dysplastic cells on smear |
| Drug-induced (hydroxyurea, methotrexate) | Impaired DNA synthesis |
| Liver disease / alcohol | Non-megaloblastic macrocytosis |
| Measure | Formula | Normal | Interpretation |
|---|---|---|---|
| Raw reticulocyte % | Retics/Total RBC Γ 100 | 1β2% | Unreliable alone in anemia |
| Corrected retic count | Retic% Γ (Pt Hct / 45) | 1β2% | Adjusts for anemia |
| RPI | CRC / Maturation factor | β₯ 2.0 (normal response) | < 2 = marrow failure; > 2.5 = hemolysis/loss |
| Absolute retic count | Retic% Γ RBC count | 25,000β75,000/Β΅L | Most direct measure of output |
What to see in newborn if child is having ctev
congenital talipes equinovarus clubfoot clinical examination findings newborn
Bailey and Love's Short Practice of Surgery 28th Edition
Page 646
clubfoot CTEV assessment Pirani score Dimeglio classification neonatal
Bailey and Love's Short Practice of Surgery 28th Edition
Page 646
CTEV clubfoot deformity components cavus adductus varus equinus
congenital talipes equinovarus clubfoot newborn examination

Hugging Face pmc clinical VQA raw
Page 0

| Component | Description | Location |
|---|---|---|
| C β Cavus | High medial longitudinal arch; plantar flexion of 1st ray | Forefoot/midfoot |
| A β Adductus | Forefoot deviated medially (inward) | Midfoot |
| V β Varus | Heel tilted inward | Hindfoot |
| E β Equinus | Foot pointed downward (plantar flexion at ankle) | Hindfoot/ankle |
All four components are present in true CTEV. The deformity is fixed, unlike postural talipes which is fully correctable.
| Sign | What to Assess |
|---|---|
| Medial crease | Depth of medial skin crease |
| Curvature of lateral border | Normally straight β curved = adductus |
| Talar head coverage | How much talar head is uncovered laterally |
| Posterior crease | Depth of posterior ankle crease |
| Rigid equinus | Degree of fixed plantarflexion |
| Empty heel | How empty/underfilled the heel feels |
| Grade | Score | Severity |
|---|---|---|
| I | 1β5 | Benign (soft-soft) |
| II | 6β10 | Moderate (soft-stiff) |
| III | 11β15 | Severe (stiff-soft) |
| IV | 16β20 | Very severe (stiff-stiff) |
| System | What to Look For |
|---|---|
| Spine | Neural tube defects, spina bifida (β neurogenic clubfoot) |
| Hips | Developmental dysplasia of hip (DDH) β check Barlow/Ortolani |
| Knees | Knee contractures, popliteal webbing |
| Upper limbs | Arthrogryposis multiplex congenita (multiple joint contractures) |
| General dysmorphism | Chromosomal syndromes (trisomy 18, 13) |
| Neurological | Tone, reflexes β rule out myelomeningocele, spinal muscular atrophy |
| Feature | True CTEV | Postural Talipes |
|---|---|---|
| Reducibility | Fixed, non-correctable | Fully correctable passively |
| Skin creases | Deep medial and posterior | Absent or shallow |
| Calf hypoplasia | Present | Absent |
| Foot size | Smaller than normal | Normal |
| Treatment | Ponseti casting + possible tenotomy | Physiotherapy/stretching |